Angiodynamic Inc (NASDAQ: ANGO) on Friday, plunged -3.36% from the previous trading day, before settling in for the closing price of $9.83. Within the past 52 weeks, ANGO’s price has moved between $5.47 and $13.50.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 2.66%. The company achieved an average annual earnings per share of 2.63%. With a float of $38.59 million, this company’s outstanding shares have now reached $40.84 million.
Let’s determine the extent of company efficiency that accounts for 748 employees. In terms of profitability, gross margin is 50.66%, operating margin of -11.52%, and the pretax margin is -82.86%.
Angiodynamic Inc (ANGO) Insider Activity
Observing investor behavior towards Medical Instruments & Supplies industry stocks is more important than anything else. The insider ownership of Angiodynamic Inc is 4.63%, while institutional ownership is 81.98%. The most recent insider transaction that took place on Jan 16 ’25, was worth 49,979. In this transaction SVP Quality and Regulatory of this company sold 4,060 shares at a rate of $12.31, taking the stock ownership to the 41,817 shares. Before that another transaction happened on Jan 16 ’25, when Company’s Officer proposed sale 4,060 for $12.31, making the entire transaction worth $49,979.
Angiodynamic Inc (ANGO) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.09 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 2.63% per share during the next fiscal year.
Angiodynamic Inc (NASDAQ: ANGO) Trading Performance Indicators
Angiodynamic Inc (ANGO) is currently performing well based on its current performance indicators. A quick ratio of 1.24 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.34.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.58, a number that is poised to hit -0.13 in the next quarter and is forecasted to reach -0.21 in one year’s time.
Technical Analysis of Angiodynamic Inc (ANGO)
Looking closely at Angiodynamic Inc (NASDAQ: ANGO), its last 5-days average volume was 0.45 million, which is a drop from its year-to-date volume of 0.69 million. As of the previous 9 days, the stock’s Stochastic %D was 50.44%. Additionally, its Average True Range was 0.44.
During the past 100 days, Angiodynamic Inc’s (ANGO) raw stochastic average was set at 41.94%, which indicates a significant decrease from 60.89% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 55.27% in the past 14 days, which was lower than the 75.41% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.45, while its 200-day Moving Average is $8.16. However, in the short run, Angiodynamic Inc’s stock first resistance to watch stands at $9.80. Second resistance stands at $10.09. The third major resistance level sits at $10.30. If the price goes on to break the first support level at $9.29, it is likely to go to the next support level at $9.08. Should the price break the second support level, the third support level stands at $8.79.
Angiodynamic Inc (NASDAQ: ANGO) Key Stats
Market capitalization of the company is 384.42 million based on 40,466K outstanding shares. Right now, sales total 303,910 K and income totals -184,350 K. The company made 72,850 K in profit during its latest quarter, and -10,740 K in sales during its previous quarter.
